FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094752648> ?p ?o ?g. }

• W2094752648 abstract "Metastasis is primarily responsible for the mortality associated with breast cancer. Despite this, the molecular underpinnings of cancer progression are poorly understood. By integrating bioinformatics with traditional genetics, we have addressed the hypothesis that genetic events mediating breast cancer metastasis can be elucidated from mouse models. To test this hypothesis, we assembled a gene expression database of over 1100 mouse breast cancers from 23 different models. Using this database, E2F transcription factors were predicted to be strikingly activated in metastatic mouse models. Transgenic MMTV-Neu mice were interbred with E2F transcription factor knockouts to test this hypothesis. Tumor latency was increased significantly with the loss of any of the activator E2Fs in the MMTV-Neu mice. Strikingly, there was also a significant reduction in the extent of pulmonary metastasis with loss of either E2F1 or E2F2. This metastasis reduction was shown to be a cell autonomous effect through a transplant experiment. Moreover, CD-31 staining revealed vasculature alterations with E2F loss. These data led to the hypothesis that E2F transcription factors were critical in mediating metastasis. Highly metastatic MMTV-PyMT transgenic mice also had predicted E2F transcription factor activation. Genetically testing this prediction, we noted that PyMT transgenic mice lacking E2F1 or E2F2 recapitulated the MMTV-Neu results with a vast reduction in metastasis. Using a tail vein injection we noted defects in extravasation with E2F1 or E2F2 loss. To determine the mechanism by which E2Fs regulated metastatic progression, we examined gene expression profiles of MMTV-Neu and PyMT tumors in both control and E2F knockout backgrounds. This analysis identified a cohort of genes with reduced expression in the non-metastatic E2F knockout breast cancers relative to the metastatic wild type E2F controls. Importantly, genes identified in the mouse model system are co-amplified in human HER2+ breast cancer but are not part of the HER2 amplicon. This amplicon is present in over 30% of HER2+ human breast cancers and is inversely associated with metastasis free survival. In addition to examining the amplicon genes in HER2+ human breast cancer, we have also examined predicted E2F activity using genomic signatures. This revealed four common combinations of E2F activity in HER2+ breast cancer. Importantly, low E2F1 and high E2F2 in the same sample was associated with far better relapse free survival than the opposite E2F pattern. These data indicate that the effects and the mechanisms uncovered in the mouse models are present in HER2+ human breast cancer. Taken together, by integrating bioinformatics with mouse models of breast cancer we have demonstrated that the E2F transcription factors play a pivotal role in progression from primary breast cancer to metastasis. Citation Format: Daniel Hollern, John Rennhack, Eran Andrechek. A mouse model gene expression database reveals E2Fs as key regulators of breast cancer metastasis. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 988. doi:10.1158/1538-7445.AM2014-988" @default.
• W2094752648 created "2016-06-24" @default.
• W2094752648 creator A5082695064 @default.
• W2094752648 creator A5084096535 @default.
• W2094752648 creator A5090347439 @default.
• W2094752648 date "2014-09-30" @default.
• W2094752648 modified "2023-10-11" @default.
• W2094752648 title "Abstract 988: A mouse model gene expression database reveals E2Fs as key regulators of breast cancer metastasis" @default.
• W2094752648 doi "https://doi.org/10.1158/1538-7445.am2014-988" @default.
• W2094752648 hasPublicationYear "2014" @default.
• W2094752648 type Work @default.
• W2094752648 sameAs 2094752648 @default.
• W2094752648 citedByCount "1" @default.
• W2094752648 countsByYear W20947526482016 @default.
• W2094752648 crossrefType "proceedings-article" @default.
• W2094752648 hasAuthorship W2094752648A5082695064 @default.
• W2094752648 hasAuthorship W2094752648A5084096535 @default.
• W2094752648 hasAuthorship W2094752648A5090347439 @default.
• W2094752648 hasConcept C102230213 @default.
• W2094752648 hasConcept C104317684 @default.
• W2094752648 hasConcept C121608353 @default.
• W2094752648 hasConcept C127716648 @default.
• W2094752648 hasConcept C141035611 @default.
• W2094752648 hasConcept C164659718 @default.
• W2094752648 hasConcept C2779013556 @default.
• W2094752648 hasConcept C502942594 @default.
• W2094752648 hasConcept C530470458 @default.
• W2094752648 hasConcept C54355233 @default.
• W2094752648 hasConcept C83258922 @default.
• W2094752648 hasConcept C86339819 @default.
• W2094752648 hasConcept C86803240 @default.
• W2094752648 hasConceptScore W2094752648C102230213 @default.
• W2094752648 hasConceptScore W2094752648C104317684 @default.
• W2094752648 hasConceptScore W2094752648C121608353 @default.
• W2094752648 hasConceptScore W2094752648C127716648 @default.
• W2094752648 hasConceptScore W2094752648C141035611 @default.
• W2094752648 hasConceptScore W2094752648C164659718 @default.
• W2094752648 hasConceptScore W2094752648C2779013556 @default.
• W2094752648 hasConceptScore W2094752648C502942594 @default.
• W2094752648 hasConceptScore W2094752648C530470458 @default.
• W2094752648 hasConceptScore W2094752648C54355233 @default.
• W2094752648 hasConceptScore W2094752648C83258922 @default.
• W2094752648 hasConceptScore W2094752648C86339819 @default.
• W2094752648 hasConceptScore W2094752648C86803240 @default.
• W2094752648 hasLocation W20947526481 @default.
• W2094752648 hasOpenAccess W2094752648 @default.
• W2094752648 hasPrimaryLocation W20947526481 @default.
• W2094752648 hasRelatedWork W1251689262 @default.
• W2094752648 hasRelatedWork W1512015234 @default.
• W2094752648 hasRelatedWork W1520856400 @default.
• W2094752648 hasRelatedWork W1966236033 @default.
• W2094752648 hasRelatedWork W1982369784 @default.
• W2094752648 hasRelatedWork W1985492248 @default.
• W2094752648 hasRelatedWork W1999323866 @default.
• W2094752648 hasRelatedWork W2034144242 @default.
• W2094752648 hasRelatedWork W2040023768 @default.
• W2094752648 hasRelatedWork W2314724080 @default.
• W2094752648 hasRelatedWork W2323174162 @default.
• W2094752648 hasRelatedWork W2333913594 @default.
• W2094752648 hasRelatedWork W2504228876 @default.
• W2094752648 hasRelatedWork W2562122437 @default.
• W2094752648 hasRelatedWork W2804338291 @default.
• W2094752648 hasRelatedWork W2951601801 @default.
• W2094752648 hasRelatedWork W2992463400 @default.
• W2094752648 hasRelatedWork W3178229283 @default.
• W2094752648 hasRelatedWork W3208153563 @default.
• W2094752648 isParatext "false" @default.
• W2094752648 isRetracted "false" @default.
• W2094752648 magId "2094752648" @default.
• W2094752648 workType "article" @default.